1. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Human molecular genetics. 2008; 17(8):1076-86.
2. Rankinen T, Perusse L, Rauramaa R, Rivera MA, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes. Medicine and science in sports and exercise. 2001; 33(6):855-67.
3. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996; 137(1):354-66.
4. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes. 2003; 52(12):2874-81.
5. Horowitz JF, Leone TC, Feng W, Kelly DP, Klein S. Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training. American journal of physiology Endocrinology and metabolism. 2000; 279(2): E348-55.
6. Ahmetov, II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, et al. PPARalpha gene variation and physical performance in Russian athletes. European journal of applied physiology. 2006; 97(1):103-8.
7. Ahmetov, II, Gavrilov DN, Astratenkova IV, Druzhevskaya AM, Malinin AV, Romanova EE, et al. The association of ACE, ACTN3 and PPARA gene variants with strength phenotypes in middle school-age children. The journal of physiological sciences : JPS. 2013; 63(1):79-85.
8. Maciejewska A, Sawczuk M, Cieszczyk P. Variation in the PPARalpha gene in Polish rowers. Journal of science and medicine in sport. 2011; 14(1):58-64.
9. Eynon N, Meckel Y, Sagiv M, Yamin C, Amir R, Sagiv M, et al. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scandinavian journal of medicine & science in sports. 2010; 20(1):e145-50.
10. Cięszczyk P, Sawczuk M, Maciejewska A, Ficek K, Eider J. Variation in peroxisome proliferator activated receptor α gene in elite combat athletes. European Journal of Sport Science. 2011; 11:119-23.
11. Ginevičienė V, Pranckevičienė E, Milašius K, Kučinskas V. Relating fitness phenotypes to genotypes in Lithuanian elite athletes. Acta medica Lituanica. 2010; 17(1-2):1-10.
12. Lopez-Leon S, Tuvblad C, Forero DA. Sports genetics: the PPARA gene and athletes' high ability in endurance sports. A systematic review and meta-analysis. Biology of sport. 2016; 33(1):3-6.
13. Ahmetov, II, Williams AG, Popov DV, Lyubaeva EV, Hakimullina AM, Fedotovskaya ON, et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Human genetics. 2009; 126(6):751-61.
14. Broos S, Windelinckx A, De Mars G, Huygens W, Peeters MW, Aerssens J, et al. Is PPARalpha intron 7 G/C polymorphism associated with muscle strength characteristics in nonathletic young men? Scandinavian journal of medicine & science in sports. 2013; 23(4):494-500.
15. Baar K. Involvement of PPARg co-activator-1, nuclear respiratory factors 1 and 2, and PPARa in the adaptive response to endurance exercise Proceedings of the Nutrition Society. 2004; 63:269-273.